Search the Journal

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

VOLUME 34: NO. 2 FEBRUARY 2007

Editorials

Rheumatoid Arthritis and Lymphoma: Risky Business for B Cells
 
G. Starkebaum .........243
→RELATED ARTICLE

Tumor Necrosis Factor-a Inhibition and Palmoplantar Pustulosis: Janus-Faced Therapy?
 
J.P. Dutz .........247
→RELATED ARTICLE

Quantitative Clinical Rheumatology N-of-1 Trial of Low-dose Methotrexate and/or Prednisone in Lieu of Anti-CCP, MRI, or Ultrasound, as First Option in Suspected Rheumatoid Arthritis?
 
T. Pincus, T.W.J. Huizinga, Y. Yazici .........250

Desensitization to Hydroxychloroquine: Alternative Interpretations
 
R.D. Sontheimer .........253

Comment Desensitization to Hydroxychloroquine
 
M. Mates, G. Nesher .........255

Renal Biopsy at the Onset of Clinical Lupus Nephritis: Can It Yield Useful Information?
 
J. Oates .........256
→RELATED ARTICLE

Magnetic Resonance Imaging for Spondyloarthritis -- Avoiding the Minefield
 
W.P. Maksymowych, R.G.W. Lambert .........259

Articles

High CCL18/PARC Expression in Articular Cartilage and Synovial Tissue of Patients with RA
   
S. Momohara, H. Okamoto, T. Iwamoto, et al .........266

Immune Responses Following Administration of Influenza and Pneumococcal Vaccines to Patients with RA Receiving Adalimumab
   
J.L. Kaine, A.J. Kivitz, C. Birbara, A.Y. Luo .........272

Determining the Minimal Clinically Important Differences in Activity, Fatigue, and Sleep Quality in Patients with RA
   
G. Wells, T. Li, L. Maxwell, R. MacLean, P. Tugwell .........280

Independent Association of Increased Trunk Fat with Increased Arterial Stiffening in Postmenopausal Patients with RA
   
M. Inaba, K. Tanaka, H. Goto, et al .........290

Hand Function and Activity Limitation According to HAQ in Patients with RA and Healthy Referents: 5-Year Followup of Predictors of Activity Limitation (The Swedish TIRA Project)
   
M.A. Björk, I.S.M. Thyberg, T. Skogh, B.U.C. Gerdle .........296

Risk Factors Associated with Incident Clinical Vertebral and Nonvertebral Fractures in Japanese Women with RA: A Prospective 54-month Observational Study
   
T. Furuya, S. Kotake, E. Inoue, et al .........303

Differences in Clinical Status Measures in Different Ethnic/Racial Groups with Early RA: Implications for Interpretation of Clinical Trial Data
   
Y. Yazici, H. Kautiainen, T. Sokka .........311

Sustained Remission and Reduced Radiographic Progression with Combination DMARD in Early RA
   
H. Mäkinen, H. Kautiainen, P. Hannonen, et al .........316

Lymphoproliferative Disorders in RA: Clinicopathological Analysis of 76 Cases in Relation to MTX Medication
   
Y. Hoshida, J-X. Xu, S. Fujita, et al .........322
→RELATED ARTICLE

Renal Biopsy in Lupus Patients with Low Levels of Proteinuria
   
L. Christopher-Stine, M. Siedner, J. Lin, et al .........332
→RELATED ARTICLE

Summarizing Disease Features Over Time: II. Variability Measures of SLEDAI-2K
   
D. Ibañez, D. Gladman, M. Urowitz .........336

Ill-defined Neurological Syndromes with Autoimmune Background: A Diagnostic Challenge
   
C.P. Mavragani, N. Patronas, M. Dalakas, H.M. Moutsopoulos .........341

The Clinical Spectrum of Catastrophic APS in the Absence and Presence of Lupus
   
U.D. Bayraktar, D. Erkan, S. Bucciarelli, G. Espinosa, R. Asherson, for the Catastrophic Antiphospholipid Syndrome Project Group .........346

Increased Serum Soluble CD40 Levels in Patients with SSc
   
K. Komura, M. Fujimoto, T. Matsushita, et al .........353

Medical Signs and Symptoms Associated with Disability, Pain, and Psychosocial Adjustment in SSc
   
V.L. Malcarne, I. Hansdottir, A. McKinney, et al .........359

Association of TLR-4 Variants and AS: A Case-Control Study
   
T. Snelgrove, S. Lim, C. Greenwood, et al .........368

Prevalence of Subclinical Amyloidosis in AS
   
G. Singh, N. Kumari, A. Aggarwal, N. Krishnani, R. Misra .........371

TLR-2 Expression Is Upregulated in Antigen-Presenting Cells from Patients with PsA: A Pathogenic Role for Innate Immunity?
   
L. Candia, J. Marquez, C. Hernandez, A.H. Zea, L.R. Espinoza .........374

Psoriasis Induced by TNF-a Antagonist Therapy: A Case Series
   
J.D. Cohen, I. Bournerias, V. Buffard, et al .........380
→RELATED ARTICLE

Descriptive Epidemiology of OA in British Columbia, Canada
   
J.A. Kopec, M.M. Rahman, J-M. Berthelot, et al .........386

Primary and Revision Hip Arthroplasty: 5-year Outcomes and Influence of Age and Comorbidity
   
A. Lübbeke, J.N. Katz, T.V. Perneger, P. Hoffmeyer .........394

Influence of Oxygen Tension on IL-1-Induced Peroxynitrite Formation and Matrix Turnover in Articular Cartilage
   
J.M. Cernanec, J.B. Weinberg, I. Batinic-Haberle, F. Guilak, B. Fermor .........401

GI Side Effects of Etoricoxib in Patients with OA: Results of the Etoricoxib versus Diclofenac Sodium GI Tolerability and Effectiveness (EDGE) Trial
   
H.S.B. Baraf, C. Fuentealba, M. Greenwald, et al, for the EDGE Study Group .........408

Design and Validation of 2 Objective Structured Clinical Examination Stations to Assess Core Undergraduate Examination Skills of the Hand and Knee
   
N. Raj, L.J. Badcock, G.A. Brown, C.M. Deighton, S.C. O'Reilly .........421

Pediatric Rheumatology

Visiting Consultant Clinics to Study Prevalence Rates of JRA and Childhood SLE Across Dispersed Geographic Areas
   
D.K. Kurahara, A. Grandinetti, L.L.A. Fujii, et al .........425

Case Reports

Serum Sickness Following Treatment with Rituximab
   
D.J. Todd, S.M. Helfgott .........430

New-Onset Psoriatic Palmoplantaris Pustulosis Following Infliximab Therapy: A Class Effect?
   
C.H. Roux, O. Brocq, N. Leccia, et al .........434
→RELATED ARTICLE

Images in Rheumatology

Psoriasis Induced by Anti-TNF Therapy: A Class Effect?
 
P. Richette, M. Viguier, H. Bachelez, T. Bardin .........438
→RELATED ARTICLE

Symmetric Peripheral Gangrene as an Emerging Manifestation of Polyarteritis Nodosa
 
T. Ninomiya, T. Sugimoto, Y. Tanaka, et al .........440

Scalp Necrosis in Giant Cell Arteritis
 
M. Mahevas, V. Delastour, G. Bussone, M. Khellaf .........442

Canadian Rheumatology Association Meeting — First Mexican-Canadian Congress of Rheumatology
  .........444

 

Correspondence

Anemia of Chronic Disease in Patients with RA — Use of Zinc Protoporphyrin Levels

S. Saravana, A. Rai .........446

Reply
 
A.J.G. Swaak .........446

TNF Can Paradoxically Increase on Etanercept Treatment, Occasionally Contributing to TNF-Mediated Disease
 
A. Bhatia, R.E. Kast .........447

Reply
 
I. Sari, N. Akkoc .........449

Whiplash and Widespread Pain
 
R. Ferrari, A.S. Russell .........450

Reply
 
M. Sterling .........450

Alberta Rodeo Riders Do Not Develop Late Whiplash
 
C. Centeno, M.D. Freeman .........451

Reply
 
R. Ferrari, A.S. Russell .........452

Letter

RS3PE Syndrome: Bad or Good Prognosis?
 
R. Queiro, M. Alperi, J.L. Riestra, J. Ballina .........452

Meetings in Rheumatology
 



Return to Archives



© 2007. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.